Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GA binding protein transcription factor subunit beta 1 (GABPB1) is the beta subunit of the GA binding protein complex, a member of the Ets family of transcription factors. GABPB1 forms a heterodimer or tetrameric complex with GABPA (alpha subunit), stimulating the transcription of target genes. It plays a crucial role in the regulation of nuclear-encoded mitochondrial genes, cell cycle progression, and the development and function of several cellular lineages including immune cells and neural stem/progenitor cells[1][2][3][4][5]. GABPB1 is expressed in multiple tissues, with essential functions in embryogenesis, neurogenesis, hematopoiesis, and immune system maturation[1][3][4]. Multiple transcript variants due to alternative splicing exist, leading to isoforms with potentially distinct biological activities[1][4]. Disruption of GABPB1 impairs stem and progenitor cell proliferation and has been associated with malignancies including retinoblastoma and roles in TERT promoter activation in cancer[3][5]. No direct pharmaceutical agents targeting GABPB1 are currently characterized in public databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GA binding protein transcription factor subunit beta 1 (GABPB1).